(2R)-2-[2-[4-[2-[bis[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]piperazin-1-yl]ethyl-[2-[1-hydroxydodecan-2-yl-[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]amino]dodecan-1-ol;(11R,15R)-13-[2-[4-[2-[2-[bis[(2R)-2-hydroxydodecyl]amino]ethyl-[(2R)-2-hydroxydodecyl]amino]ethyl]piperazin-1-yl]ethyl]pentacosane-11,15-diol

C141H291N9O10 — CID 157339733

IUPAC(2R)-2-[2-[4-[2-[bis[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]piperazin-1-yl]ethyl-[2-[1-hydroxydodecan-2-yl-[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]amino]dodecan-1-ol;(11R,15R)-13-[2-[4-[2-[2-[bis[(2R)-2-hydroxydodecyl]amino]ethyl-[(2R)-2-hydroxydodecyl]amino]ethyl]piperazin-1-yl]ethyl]pentacosane-11,15-diol
SMILESCCCCCCCCCCC(CO)N(CCN(CCN1CCN(CCN([C@@H](CO)CCCCCCCCCC)[C@@H](CO)CCCCCCCCCC)CC1)[C@@H](CO)CCCCCCCCCC)[C@@H](CO)CCCCCCCCCC.CCCCCCCCCC[C@@H](O)CC(CCN1CCN(CCN(CCN(C[C@H](O)CCCCCCCCCC)C[C@H](O)CCCCCCCCCC)C[C@H](O)CCCCCCCCCC)CC1)C[C@H](O)CCCCCCCCCC
InChIInChI=1S/C71H146N4O5.C70H145N5O5/c1-6-11-16-21-26-31-36-41-46-67(76)61-66(62-68(77)47-42-37-32-27-22-17-12-7-2)51-52-72-53-55-73(56-54-72)57-58-74(63-69(78)48-43-38-33-28-23-18-13-8-3)59-60-75(64-70(79)49-44-39-34-29-24-19-14-9-4)65-71(80)50-45-40-35-30-25-20-15-10-5;1-6-11-16-21-26-31-36-41-46-66(61-76)73(58-60-75(69(64-79)49-44-39-34-29-24-19-14-9-4)70(65-80)50-45-40-35-30-25-20-15-10-5)57-55-71-51-53-72(54-52-71)56-59-74(67(62-77)47-42-37-32-27-22-17-12-7-2)68(63-78)48-43-38-33-28-23-18-13-8-3/h66-71,76-80H,6-65H2,1-5H3;66-70,76-80H,6-65H2,1-5H3/t67-,68-,69-,70-,71-;66-,67-,68-,69-,70?/m11/s1
InChIKeyBGGINNNLTGAMSX-SCOKKRBXSA-N
MW2272.93 g/mol
LogP33.42
Rot. Bonds128

About (2R)-2-[2-[4-[2-[bis[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]piperazin-1-yl]ethyl-[2-[1-hydroxydodecan-2-yl-[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]amino]dodecan-1-ol;(11R,15R)-13-[2-[4-[2-[2-[bis[(2R)-2-hydroxydodecyl]amino]ethyl-[(2R)-2-hydroxydodecyl]amino]ethyl]piperazin-1-yl]ethyl]pentacosane-11,15-diol

(2R)-2-[2-[4-[2-[bis[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]piperazin-1-yl]ethyl-[2-[1-hydroxydodecan-2-yl-[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]amino]dodecan-1-ol;(11R,15R)-13-[2-[4-[2-[2-[bis[(2R)-2-hydroxydodecyl]amino]ethyl-[(2R)-2-hydroxydodecyl]amino]ethyl]piperazin-1-yl]ethyl]pentacosane-11,15-diol (PubChem CID 157339733) has the molecular formula C141H291N9O10 and a molecular weight of 2272.93 g/mol. Its IUPAC name is (2R)-2-[2-[4-[2-[bis[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]piperazin-1-yl]ethyl-[2-[1-hydroxydodecan-2-yl-[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]amino]dodecan-1-ol;(11R,15R)-13-[2-[4-[2-[2-[bis[(2R)-2-hydroxydodecyl]amino]ethyl-[(2R)-2-hydroxydodecyl]amino]ethyl]piperazin-1-yl]ethyl]pentacosane-11,15-diol.

Molecular Properties

Compound Name(2R)-2-[2-[4-[2-[bis[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]piperazin-1-yl]ethyl-[2-[1-hydroxydodecan-2-yl-[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]amino]dodecan-1-ol;(11R,15R)-13-[2-[4-[2-[2-[bis[(2R)-2-hydroxydodecyl]amino]ethyl-[(2R)-2-hydroxydodecyl]amino]ethyl]piperazin-1-yl]ethyl]pentacosane-11,15-diol
PubChem CID157339733
Molecular FormulaC141H291N9O10
Molecular Weight2272.93 g/mol
Exact Mass2271.25
IUPAC Name(2R)-2-[2-[4-[2-[bis[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]piperazin-1-yl]ethyl-[2-[1-hydroxydodecan-2-yl-[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]amino]dodecan-1-ol;(11R,15R)-13-[2-[4-[2-[2-[bis[(2R)-2-hydroxydodecyl]amino]ethyl-[(2R)-2-hydroxydodecyl]amino]ethyl]piperazin-1-yl]ethyl]pentacosane-11,15-diol
SMILESCCCCCCCCCCC(CO)N(CCN(CCN1CCN(CCN([C@@H](CO)CCCCCCCCCC)[C@@H](CO)CCCCCCCCCC)CC1)[C@@H](CO)CCCCCCCCCC)[C@@H](CO)CCCCCCCCCC.CCCCCCCCCC[C@@H](O)CC(CCN1CCN(CCN(CCN(C[C@H](O)CCCCCCCCCC)C[C@H](O)CCCCCCCCCC)C[C@H](O)CCCCCCCCCC)CC1)C[C@H](O)CCCCCCCCCC
InChIInChI=1S/C71H146N4O5.C70H145N5O5/c1-6-11-16-21-26-31-36-41-46-67(76)61-66(62-68(77)47-42-37-32-27-22-17-12-7-2)51-52-72-53-55-73(56-54-72)57-58-74(63-69(78)48-43-38-33-28-23-18-13-8-3)59-60-75(64-70(79)49-44-39-34-29-24-19-14-9-4)65-71(80)50-45-40-35-30-25-20-15-10-5;1-6-11-16-21-26-31-36-41-46-66(61-76)73(58-60-75(69(64-79)49-44-39-34-29-24-19-14-9-4)70(65-80)50-45-40-35-30-25-20-15-10-5)57-55-71-51-53-72(54-52-71)56-59-74(67(62-77)47-42-37-32-27-22-17-12-7-2)68(63-78)48-43-38-33-28-23-18-13-8-3/h66-71,76-80H,6-65H2,1-5H3;66-70,76-80H,6-65H2,1-5H3/t67-,68-,69-,70-,71-;66-,67-,68-,69-,70?/m11/s1
InChIKeyBGGINNNLTGAMSX-SCOKKRBXSA-N
XLogP33.42
TPSA231.46 Ų
H-Bond Donors10
H-Bond Acceptors19
Rotatable Bonds128
Heavy Atoms160
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002272.93
LogP ≤ 533.42
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (2R)-2-[2-[4-[2-[bis[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]piperazin-1-yl]ethyl-[2-[1-hydroxydodecan-2-yl-[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]amino]dodecan-1-ol;(11R,15R)-13-[2-[4-[2-[2-[bis[(2R)-2-hydroxydodecyl]amino]ethyl-[(2R)-2-hydroxydodecyl]amino]ethyl]piperazin-1-yl]ethyl]pentacosane-11,15-diol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-2-[2-[4-[2-[bis[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]piperazin-1-yl]ethyl-[2-[1-hydroxydodecan-2-yl-[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]amino]dodecan-1-ol;(11R,15R)-13-[2-[4-[2-[2-[bis[(2R)-2-hydroxydodecyl]amino]ethyl-[(2R)-2-hydroxydodecyl]amino]ethyl]piperazin-1-yl]ethyl]pentacosane-11,15-diol?
The IUPAC name of (2R)-2-[2-[4-[2-[bis[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]piperazin-1-yl]ethyl-[2-[1-hydroxydodecan-2-yl-[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]amino]dodecan-1-ol;(11R,15R)-13-[2-[4-[2-[2-[bis[(2R)-2-hydroxydodecyl]amino]ethyl-[(2R)-2-hydroxydodecyl]amino]ethyl]piperazin-1-yl]ethyl]pentacosane-11,15-diol (CID 157339733) is (2R)-2-[2-[4-[2-[bis[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]piperazin-1-yl]ethyl-[2-[1-hydroxydodecan-2-yl-[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]amino]dodecan-1-ol;(11R,15R)-13-[2-[4-[2-[2-[bis[(2R)-2-hydroxydodecyl]amino]ethyl-[(2R)-2-hydroxydodecyl]amino]ethyl]piperazin-1-yl]ethyl]pentacosane-11,15-diol.
What is the SMILES notation for (2R)-2-[2-[4-[2-[bis[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]piperazin-1-yl]ethyl-[2-[1-hydroxydodecan-2-yl-[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]amino]dodecan-1-ol;(11R,15R)-13-[2-[4-[2-[2-[bis[(2R)-2-hydroxydodecyl]amino]ethyl-[(2R)-2-hydroxydodecyl]amino]ethyl]piperazin-1-yl]ethyl]pentacosane-11,15-diol?
The canonical SMILES for (2R)-2-[2-[4-[2-[bis[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]piperazin-1-yl]ethyl-[2-[1-hydroxydodecan-2-yl-[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]amino]dodecan-1-ol;(11R,15R)-13-[2-[4-[2-[2-[bis[(2R)-2-hydroxydodecyl]amino]ethyl-[(2R)-2-hydroxydodecyl]amino]ethyl]piperazin-1-yl]ethyl]pentacosane-11,15-diol is CCCCCCCCCCC(CO)N(CCN(CCN1CCN(CCN([C@@H](CO)CCCCCCCCCC)[C@@H](CO)CCCCCCCCCC)CC1)[C@@H](CO)CCCCCCCCCC)[C@@H](CO)CCCCCCCCCC.CCCCCCCCCC[C@@H](O)CC(CCN1CCN(CCN(CCN(C[C@H](O)CCCCCCCCCC)C[C@H](O)CCCCCCCCCC)C[C@H](O)CCCCCCCCCC)CC1)C[C@H](O)CCCCCCCCCC.
What is the InChIKey of (2R)-2-[2-[4-[2-[bis[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]piperazin-1-yl]ethyl-[2-[1-hydroxydodecan-2-yl-[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]amino]dodecan-1-ol;(11R,15R)-13-[2-[4-[2-[2-[bis[(2R)-2-hydroxydodecyl]amino]ethyl-[(2R)-2-hydroxydodecyl]amino]ethyl]piperazin-1-yl]ethyl]pentacosane-11,15-diol?
The InChIKey is BGGINNNLTGAMSX-SCOKKRBXSA-N. The full InChI is InChI=1S/C71H146N4O5.C70H145N5O5/c1-6-11-16-21-26-31-36-41-46-67(76)61-66(62-68(77)47-42-37-32-27-22-17-12-7-2)51-52-72-53-55-73(56-54-72)57-58-74(63-69(78)48-43-38-33-28-23-18-13-8-3)59-60-75(64-70(79)49-44-39-34-29-24-19-14-9-4)65-71(80)50-45-40-35-30-25-20-15-10-5;1-6-11-16-21-26-31-36-41-46-66(61-76)73(58-60-75(69(64-79)49-44-39-34-29-24-19-14-9-4)70(65-80)50-45-40-35-30-25-20-15-10-5)57-55-71-51-53-72(54-52-71)56-59-74(67(62-77)47-42-37-32-27-22-17-12-7-2)68(63-78)48-43-38-33-28-23-18-13-8-3/h66-71,76-80H,6-65H2,1-5H3;66-70,76-80H,6-65H2,1-5H3/t67-,68-,69-,70-,71-;66-,67-,68-,69-,70?/m11/s1.
What are the key properties of (2R)-2-[2-[4-[2-[bis[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]piperazin-1-yl]ethyl-[2-[1-hydroxydodecan-2-yl-[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]amino]dodecan-1-ol;(11R,15R)-13-[2-[4-[2-[2-[bis[(2R)-2-hydroxydodecyl]amino]ethyl-[(2R)-2-hydroxydodecyl]amino]ethyl]piperazin-1-yl]ethyl]pentacosane-11,15-diol?
(2R)-2-[2-[4-[2-[bis[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]piperazin-1-yl]ethyl-[2-[1-hydroxydodecan-2-yl-[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]amino]dodecan-1-ol;(11R,15R)-13-[2-[4-[2-[2-[bis[(2R)-2-hydroxydodecyl]amino]ethyl-[(2R)-2-hydroxydodecyl]amino]ethyl]piperazin-1-yl]ethyl]pentacosane-11,15-diol has a molecular weight of 2272.93 g/mol, XLogP of 33.42, 128 rotatable bonds, 10 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-[2-[4-[2-[bis[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]piperazin-1-yl]ethyl-[2-[1-hydroxydodecan-2-yl-[(2R)-1-hydroxydodecan-2-yl]amino]ethyl]amino]dodecan-1-ol;(11R,15R)-13-[2-[4-[2-[2-[bis[(2R)-2-hydroxydodecyl]amino]ethyl-[(2R)-2-hydroxydodecyl]amino]ethyl]piperazin-1-yl]ethyl]pentacosane-11,15-diol is sourced from PubChem (CID 157339733), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).